Commentary
The Round of 32 Results: Issues Emerge, Pain Points Crystallize, and 16 Trends Move Forward
It’s tipoff time at the 6th annual March Healthcare Classic! This year’s bracket is stacked with the potential for wild upsets, blueblood domination, Cinderella runs – and the power trends that could reshape the industry in 2026. In the opening round, our four regions – Providers, Purchasers and Plans, Policy, and Pioneers – each send eight contenders to the court, all battling for a spot in the Round of 16.
There’s a twist this year: A new association rule puts the outcome in the hands of the voters, adding fresh drama to every matchup. Along the way, our region-specific panels of expert analysts will break down the action, offering insight on which trends have the strength and staying power to go the distance.
Which healthcare trend will cut down the nets in 2026? Let the games begin!
Explore the interactive bracket and join the weekly tournament on our LinkedIn page, where your vote helps choose the winner!
THE PROVIDERS REGION
AI Becomes the New Clinical Infrastructure Rejects Prior Authorization Revolution
This matchup paired a tournament mainstay with a scrappy reformer. As providers ramp up pushback through automation and advocacy, Prior Authorization Revolution (8) entered with real momentum, but it couldn’t match the scale and trajectory of AI Becomes the New Clinical Infrastructure (1). After five years developing in the Pioneers region, AI makes its debut in the traditionally tough Providers bracket – a signal of just how far it’s come. Backed by an experienced coaching staff that is helping the team rapidly translate potential into performance, this trend is already reshaping how care is delivered. In a decisive pummeling, the number one seed advances to the Round of 16.
“AI IS THE MOST EXCITING THING HAPPENING IN HEALTHCARE. THE LEVEL OF INVESTMENT, THE NUMBER OF USE CASES, THE SPEED OF ADOPTION – IN 2026, WE ARE MOVING WELL PAST THE PILOT PHASE.”
Workforce Challenges Reshape Care Delivery Dismisses Hospital at Home Goes Mainstream
Both teams in this matchup usually make it into the tournament due to the pernicious problem of health worker shortages and the eternal hope that treating people at home could control healthcare costs. But there was little excitement among analysts for this game, with discussion oriented around which team would fall in this round and which would fall in the next, even though everyone seems to agree that both Workforce Challenges Reshape Care Delivery (5) and Hospital at Home Goes Mainstream (4) are legitimate trends – just not the kind of trend that wins tournaments. In this round, the deciders have chosen Hospital at Home to… go home.
“THE WORKFORCE CHALLENGES CAN’T BE OVERLOOKED. THE NUMBERS ARE INCREASINGLY STAGGERING, AND IN RESPONSE, THE INDUSTRY HAS CREATED ENTIRELY DIFFERENT TYPES OF CARE MODELS.”
Ambulatory and Outpatient Expansion Denied by The Aging Demand Crunch
While it could be argued that ambulatory and outpatient care is one solution to the growing healthcare demand of aging patients, in this matchup The Aging Demand Crunch (6) leveraged its bench strength to upset Ambulatory and Outpatient Expansion (3). In this close game, voters saluted the tsumami wave that is older patients, who are both more numerous and more complicated, with care that often involves multiple chronic conditions on top of frailty. They are boomers, hear them roar, and they are moving on to the next round!
“THE VOLUME FROM AGING DEMAND IS HERE. THE QUESTION IS WHETHER YOU’RE RESPONDING IN A WAY THAT’S GOING TO WORK FINANCIALLY OR NOT.”
Performance Under Margin Pressure Stunned by Cybersecurity as a Clinical Priority
This game of the day was a true bracket-buster. Cybersecurity as a Clinical Priority (7) came in low on the radar but wasted no time taking control, catching Performance Under Margin Pressure (2) off balance from the opening minutes. Analysts had pegged margin pressure as a potential title contender, but this matchup proved just how vulnerable even the strongest players can be. Cybersecurity as a Clinical Priority played a near-perfect game, and with no room for error, none was given. More than 70% of breaches now disrupt patient care, and the stakes are simply too high for missteps. While margin pressure may have been the more complete team on paper, it was outmaneuvered here, a stark reminder of how quickly operations can derail when a cyber incident hits.
“LABOR COSTS, LAGGING REIMBURSEMENT, RISING ACUITY, AND INCREASED MEDICARE UTILIZATION ARE ALREADY SQUEEZING MARGINS THIN, BUT A SINGLE CYBERSECURITY INCIDENT CAN INSTANTLY PULL FOCUS AND UPEND EVERYTHING.”
THE PURCHASERS AND PLANS REGION
Employers Rewrite the Benefits Playbook Bulldozes Regional Health Plans Consolidate
No surprises in this game, as the battling ram Employers Rewrite the Benefits Playbook (1) made quick work of Regional Health Plans Consolidate (8) without breaking a sweat. Although experts agreed that regional plans are consolidating – the trend is real – some pointed to this as just more fuel for the wildfire that is the growing effect of employers on healthcare. Voters send employers on to the Round of 16.
“EMPLOYERS AND THEIR HR AND FINANCE LEADERS ARE TAKING A PROGRESSIVE, OFFENSIVE POSITION TO BRING COST CONTROL TO THE TRENDS THAT HAVE SIMPLY MOVED IN THE WRONG DIRECTION FOR TOO LONG.”
Consumerization of Healthcare Demand Flattens Product Specialization Accelerates
This contest between two well-matched, mid-field teams featured strong proponents on each side scoring points on which trend is doing more to meet the healthcare needs of modern patients. Is it Consumerization of Healthcare Demand (4), which is opening more direct channels for patients to care for themselves, or is it Product Specialization Accelerates (5), the effort of health plans to offer more specialized products tailored to specific populations? In a second half rally, consumers pull away from product specialization and advance to the next round.
“THERE ARE SO MANY LEVERS THAT ENCOURAGE PEOPLE TO TAKE CONTROL OF THEIR HEALTH AND MORE DATA AVAILABLE THAN EVER BEFORE.”
VBC Enters Its Prove-It Era Shut Out by Acceleration of Direct Contracting
Perhaps coasting in on its tournament darling status, Value-Based Care Enters Its Prove-It Era (3) was wholly unprepared for the momentum brought by Acceleration of Direct Contracting (6) – or maybe the moment of reckoning here already came and went. Either way, voters have decided that the future is direct contracting, as employers are increasingly going direct for employee care and bypassing traditional insurance channels to gain greater cost control, transparency, and access. In a tremendous upset, Acceleration of Direct Contracting leaves VBC wondering what just happened.
“EMPLOYERS ARE LOOKING TO SAVE COSTS. THIS IS ONE WAY OF DOING IT, AND I THINK IT’S A VERY EFFECTIVE WAY OF DOING IT.”
Rx Cost Control Intensifies Runs Over Medicare Advantage Rebalancing
With great respect to Medicare Advantage Rebalancing (7), a team from a legendary tournament franchise with teams that have made it into the Round of 4 once and the championship game twice (but have never won the title), they did not bring their A-game to the March Healthcare Classic this year. Or maybe even 35 million plan members just didn’t stand a chance against Rx Cost Control Intensifies (2), a trend that represents 30% of all healthcare spend – which has doubled in just a few years, fueled by specialty drugs and high-demand therapies like GLP-1s. We’ll probably see you again next year, Medicare Advantage!
“DRUG COSTS ARE A STEAMROLLER, AND THEY ARE FORCING US TO SEEK INNOVATIVE WAYS TO OFFSET THOSE COSTS.”
THE POLICY REGION
OBBBA Rewrites Individual Coverage Rules Deletes Rural Health Transformation
Unlike every other game in this round, expert analysts did not agree with the official vote. In fact, sentiment was quite polarized, with most policy experts throwing their support for an upset by Rural Health Transformation (8) and voters overwhelmingly picking OBBBA Rewrites Individual Coverage (1), an interesting twist that was bound to happen eventually under new tournament rules. Experts felt that the $50 billion Rural Health Transformation Program will absolutely make a difference, while voters believe that effects of the One Big Beautiful Bill Act on enrollment and pricing will be more significant.
“THE ONE BIG, BEAUTIFUL BILL SETS THE FOUNDATION FOR HOW COVERAGE WORKS IN THE INDIVIDUAL MARKET, AND ANYTIME YOU CHANGE SUBSIDY STRUCTURES AND AFFORDABILITY, YOU CHANGE WHO SHOWS UP IN THE SYSTEM AND WHERE THEY SEEK CARE.”
Price Transparency Enforcement Crushes Healthcare M&A Under Fire
Healthcare M&A Under Fire (5) came in with a lot of energy and excitement from policy wonks, but Price Transparency Enforcement (4) had the hearts of the fans. As these two duked it out, noise from the price transparency fans with their bloodlust for transparency rules enforcement rattled the healthcare M&A trend, despite heightened scrutiny in 2026 as the FTC, DOJ, and HHS target potentially anticompetitive deals. Experts were split, but voters were decisive, and Price Transparency Enforcement moves on to the Round of 16.
Telehealth at a Crossroads Crosses Out Interoperability Gains Ground
In this “Battle of the E-Health,” Interoperability Gains Ground (6) came in as another fan favorite, with high hope of 2026 being the year interoperability goes deep into the tournament – and further into portable electronic health records. Alas, despite a close game that went point for point almost the entire clock, Telehealth at a Crossroads (3) took advantage of interoperability’s frustrating lack of get-up-and-go and proved to be the more nimble, forward moving trend. Congratulations, Telehealth at a Crossroads!
“THE AMERICAN CONSUMER EXPECTS AND DEMANDS INTEROPERABILITY.”
Drug Pricing Shakeup Shakes Down Specialists Under the Value Lens
Specialists Under the Value Lens (7) – although elated just to be in the tournament – had no weapons in their arsenal to match the muscle of Drug Pricing Shakeup (2). A smorgasbord of drug pricing reform policies in 2026 are reshaping how plans structure formularies, how patients experience costs, and how providers and manufacturers manage revenue. Although two mandatory value-based care models are forcing specialists into risk arrangements, voters agreed that this will be a relative blip on the radar compared with drug pricing policy. Welcome to the Round of 16, Drug Pricing Shakeup!
“WHEN PEOPLE TALK ABOUT HEALTHCARE AFFORDABILITY, DRUG PRICING IS WHAT THEY’RE TALKING ABOUT. THIS IS THE HOTTEST ISSUE OUT THERE. THIS IS THE TEAM TO WATCH.”
THE PIONEERS REGION
The Health Tech ROI Reckoning Elbows Out The End of “Virtual as Add-on”
This contest between two future-forward trends was more of a game than expected, and The End of Virtual as Add-on (8) came frighteningly close to upsetting The Health Tech ROI Reckoning (1). However, despite the increased interest and emphasis around digital care delivery, the recalibration in the health tech and AI startup market has seriously weeded out speculation, and health plans are no longer playing as they rein in tech spending. The win goes to The Health Tech ROI Reckoning.
“HEALTH PLANS AND SYSTEMS ARE CONCENTRATING THEIR DIGITAL HEALTH AND AI SPEND INTO FEWER VENDORS, AND THEY’RE EMPHASIZING THE YIELD THAT THOSE FEW VENDORS CAN DELIVER.”
Home-Based Care Becomes Scalable Evicted by Next-Gen Chronic Care
In this mid-field matchup, both voters and analysts expressed strong support for home-based care and its win-win potential across the system. But the sheer weight and urgency of chronic disease – called “the most costly problem” in healthcare by analysts – ultimately tipped the scales. After a tight back-and-forth battle and bucket-for-bucket trading, Next-Gen Chronic Care (5) pulled ahead late to push past Home-Based Care Becomes Scalable (4) and punch its ticket to the Round of 16.
“HOME-BASED CARE STILL FACES HEADWINDS, BUT WE SHOULDN’T BE BRINGING PEOPLE INTO THE OFFICE JUST TO TELL THEM THEY’RE FINE.”
Consumers Take Health Optimization Direct Smokes Cell & Gene Therapy Boom
The star power of pending FDA decisions and a projected global market surge made Cell & Gene Therapy Boom (3) a formidable challenger, but its long-term promise couldn’t overcome the immediate and explosive momentum of Consumers Take Health Optimization Direct (6). Fueled by direct-to-consumer diagnostics and retail health optimization products, patients are increasingly bypassing traditional gatekeepers to take control of their own care and emerging as a surprising new source of competition for providers – and moving on to the Round of 16.
“I’VE NEVER HEARD SO MANY PEOPLE TALK ABOUT THEIR LABS.”
AI Powers Drug Discovery Eviscerates Funding Falls Short for Femtech
This matchup brought a compelling contrast between untapped potential and unstoppable forward motion. Funding Falls Short for Femtech (7) entered as women’s health always does in this tournament, representing a massive, underserved market and a baffling lack of investment. Despite this high growth potential, this trend buckled under the muscle of AI Powers Drug Discovery (2), a trend that has quickly become one of the most transformative forces in pharmaceuticals. Voters and analysts alike overwhelmingly signaled strong confidence in AI’s near-term impact and scalability, and this trend advances in commanding fashion.